Clinical Trials Browser

Phase 3 × INDUSTRY × Prostatic Neoplasms, Castration-Resistant × Clear all

NCT03748641 2026-03-16

MAGNITUDE

Phase 3 Active not recruiting

765 enrolled 16 charts 1 FDA

Prostatic Neoplasms, Castration-Resistant

NCT07225946 2026-03-13

KLK2-PASenger

Phase 3 Recruiting

Prostatic Neoplasms, Castration-Resistant

NCT03016312 2024-08-09

IMbassador250

Phase 3 Completed

759 enrolled 22 charts

Prostatic Neoplasms, Castration-Resistant

NCT04844749 2024-02-05

VERACITY

Phase 3 Terminated

Prostatic Neoplasms, Castration-Resistant

NCT02057666 2021-04-23

TasQ003

Phase 3 Terminated

146 enrolled 13 charts

Neoplasm Metastasis, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant